Clinical News

Expert panel recommends Covaxin for phase 2/3 trials on 2-18 year-olds
eMediNexus, 12 May 2021
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pediatrics
An expert panel has recommended Bharat Biotechs COVID-19 vaccine ndash Covaxin - for phase II III clinical trials on individuals aged 2 to 18 years reported official sources ...MORE
565 Views
1 Comments
Pfizer asks UK regulator to approve COVID-19 vaccine for adolescents
eMediNexus, 12 May 2021
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist
Data has been submitted by Pfizer Inc on its COVID-19 vaccine among adolescents aged 12 to 15 years to UK rsquo s health regulator reported a company spokesman ...MORE
506 Views
0 Comments
New monoclonal antibody drug helps COVID patients breathe on their own
eMediNexus, 11 May 2021
#Business And Medicine #Emergency Medicine #Hospital Medicine #Infectious Diseases #Internal Medicine
As a new monoclonal antibody drug was added to treatments for hospitalized COVID-19 patients who were still breathing on their own the drug - lenzilumab ndash led to significant improve ...MORE
699 Views
0 Comments
UK Allows Hugging Close Family and Friends as it Eases Lockdown
eMediNexus, 11 May 2021
#Business And Medicine #Emergency Medicine #Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine
People in the United Kingdom will now be able to hug close family and friends and meet indoors at pubs restaurants and cinemas from next week as the lockdown rules are eased further ...MORE
504 Views
0 Comments
WHO classifies virus strain in India as 'variant of concern'
eMediNexus, 11 May 2021
#Business And Medicine #Emergency Medicine #Hospital Medicine #Infectious Diseases #Pathology and Lab Medicine
Health experts have declared the coronavirus mutation in India as a variant of concern The World Health Organization in Geneva stated that the ...MORE
738 Views
0 Comments
FDA Authorizes Pfizer-BioNTech Vaccine for Emergency Use in Adolescents
eMediNexus, 11 May 2021
#Business And Medicine #Emergency Medicine #Infectious Diseases #Pathology and Lab Medicine #Pharmacist
The U S Food and Drug Administration has expanded the emergency use authorization EUA for the Pfizer-BioNTech COVID-19 vaccine to now include adolescents 12 to 15 years of age nbsp ...MORE
573 Views
0 Comments
Prev45678Next